Le Lézard
Classified in: Health
Subjects: SVY, WOM

Global In-vitro diagnostics instruments market is expected to grow with a CAGR of 9.3% from 2017 to 2023


NEW YORK, Nov. 15, 2017 /PRNewswire/ -- The report on global In-vitro diagnostics instruments market provides qualitative and quantitative analysis for the period of 2015 to 2023.

Read the full report: https://www.reportlinker.com/p05203571

The report predicts the global In-vitro diagnostics instruments market to grow with a CAGR of 9.3% from 2017 to 2023. The global In-vitro diagnostics instruments market was worth USD 25.86 billion in 2016. The study on In-vitro diagnostics instruments market covers the analysis of regions such as North America, Europe, Asia Pacific, and Rest of the World. Among the geographies Asia Pacific dominated the world market while as well as anticipated to grow at the highest CAGR over the forecast period.

The report on global In-vitro diagnostics instruments market is a comprehensive study of demand, market size, forecasts, trends and factors affecting the global In-vitro diagnostics instruments market. Moreover, the report is collective presentation of primary and secondary research findings. In addition, it provides deep insights on the factors that are driving, restraining the global In-vitro diagnostics instruments market. Porter's five forces model in the report provides insights into the competitive rivalry in the global In-vitro diagnostics instruments market over the period of 2015 ? 2023. Further, IGR- Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.

Research methodology

? Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached through
1. Key Opinion Leaders associated with Infinium Global Research
2. Internal and External subject matter experts
3. Professionals and participants from LinkedIn, Hoovers, Factiva and Bloggers

Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

? Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources. The secondary sources of the data typically include
? Company reports and publications
? Government/institutional publications
? Trade and associations' journals
? Databases such as WTO, OECD, and World Bank, among others.
? Websites and publications by research agencies

Report Findings
1) Drivers
? Growing elderly (Geriatric) population
? Rise in occurrence and frequency of chronic diseases and infections
? Rise in diagnoses population is due to increase in disease like malaria, diabetes, Cancer, tuberculosis, and cardiovascular disease.
? Adoption of Point-Of-Care testing.
2) Restraints
? Increasing healthcare costs and lowering compensation affecting instrument sales
3) Opportunities
? Increasing investments in emerging economies
? Increasing implication of friendly diagnosis

Segments Covered
1) Global In-vitro diagnostics instruments market by Product
a. Immunochemistry
b. clinical microbiology
c. POCT
d. tissue diagnostics
e. molecular diagnostics
f. hematology
g. hemostasis
h. SMBG
2) Global In-vitro diagnostics instruments market by End user
a. Hospitals and Diagnostic Laboratories
b. Homecare
c. Academic and Research Institutes.

Companies Profiled:
o Abbott Laboratories, Inc.
o Siemens AG
o Sysmex Corporation
o Becton
o Dickinson and Company
o Ortho-Clinical Diagnostics, Inc.
o Bio-Rad Laboratories, Inc.
o Danaher Corporation
o Thermo Fisher Scientific, Inc.
o Qiagen N.V.
o Johnson & Johnson
o Roche Diagnostics
o Diasorin S.P.A.
o Biomérieux SA.

Reasons to buy this report
1) Comprehensive analysis of global as well as regional markets of In-vitro diagnostics instruments
2) Complete coverage of all the product type and end user segments to analyze the trends, developments in In-vitro diagnostics instruments market, and forecast of market size up to 2023.
3) Comprehensive analysis of the companies operating in In-vitro diagnostics instruments market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4) Infinium Global Research- Growth Matrix presents analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Read the full report: https://www.reportlinker.com/p05203571

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker


These press releases may also interest you

at 18:24
The scheduled merits hearing dates, April 26 and 29, 2024, in the above-named matter will proceed by videoconference. On April 26, 2024, the hearing will commence 11:15 a.m. Members of the public may observe the hearing by videoconference, by...

at 17:55
Valeo Pharma Inc. ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced the results of the matters submitted to shareholders at its annual meeting of shareholders held on April 25, 2024 (the "Meeting")....

at 17:43
Community Healthcare Trust Incorporated today announced that its Board of Directors has increased its common stock cash dividend for the quarter ended March 31, 2024. This dividend, in the amount of $0.46 per share, is payable on May 24, 2024 to...

at 17:31
DelveInsight's Urine Output Monitoring Systems Market Insights report provides the current and forecast market analysis, individual leading urine output monitoring systems companies' market...

at 17:00
Enghouse Video, a global leader in cutting-edge video technology solutions, today announced its partnership with SONIFI Health, enhancing virtual care in hospital settings. SONIFI Health is a leading U.S. healthcare technology company based in Sioux...

at 17:00
A record 3,618 graduating students and physicians matched to residency training programs in Canada in this year's R-1 Main Residency Match (R-1 match), the Canadian Resident Matching Service (CaRMS) announced today....



News published on and distributed by: